US Patent 7354583 Antibody-induced apoptosis
Patent 7354583 was granted and assigned to Amgen on April, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Tsutomu Arakawa0
Yoshiko Kita0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells are disclosed. The antibodies are used to “tag” Her2 overexpressing tumors for elimination by the host immune system. Also disclosed are hybridoma cell lines producing the antibodies, methods for treating cancer using the antibodies, and pharmaceutical compositions.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07354583 Antibody-induced apoptosis US Patent 7354583 Antibody-induced apoptosis
Infobox
Patent Number
073545830
Patent Number
73545830
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073545830
Date of Patent
April 8, 2008
0Patent Application Number
099940680
Date Filed
November 27, 2001
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07354583 Antibody-induced apoptosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07354583
Date of patent
April 8, 2008
Patent application number
09994068
Date Filed
November 27, 2001
Patent primary examiner
Find more entities like US Patent 7354583 Antibody-induced apoptosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.